文献速递耳科与耳神经小儿耳鼻咽喉

中国645例听神经病患者27年听觉功能与自然史研究

Auditory Function and Natural History of 645 Auditory Neuropathy Patients Over a 27-Year Span in China.
PubMed 文献 · Ear Hear · 2025-11-21

该回顾性病例系列纳入中国解放军总医院1997年至2023年诊断的645例听神经病患者,分析从新生儿到成人的听觉功能与自然史。研究发现不同年龄组在ABR、DPOAE、镫骨肌反射阈、纯音平均听阈、40Hz听觉事件相关电位及言语识别得分进展上存在显著差异,而CM引出率始终为96.36%至100%。随访显示ABR持续异常或缺失,DPOAE逐渐消失,CM保持稳定,言语识别能力持续较差。

要点

  • CM引出率在新生儿至成人各年龄段为96.36%至100%,是评估外毛细胞功能的重要指标。
  • 随访中DPOAE逐渐消失但CM保持稳定,言语识别得分持续较差且不可改变。
  • OTOF和ATP1A3突变携带者发病早且听阈差,AIFM1突变携带者发病晚且听阈较好。

核心结论

  • 疾病意识、听力筛查和诊断方法的进步使听神经病得以早期发现和诊断。
  • 随访结果强调CM在评估外毛细胞功能中的重要性。
  • 听神经病患者听力损失进展频率较高,但言语识别能力持续较差且不可改变。

研究设计与样本

  • 所有患者均具有缺失或异常的听性脑干反应、正常或轻度改变的耳声发射和/或耳蜗微音电位,且为双耳发病。

主要发现

  • 患者来自中国29个省份和11个不同民族,听神经病诊断率从每年1例至每年44例不等。
  • 从新生儿到成人,ABR、畸变产物耳声发射、声镫骨肌反射阈、纯音平均听阈、40Hz听觉事件相关电位引出率及言语识别得分进展存在统计学显著差异。
  • CM引出率从新生儿到成人为96.36%至100%。
  • 相当大比例听神经病患者听力损失主要影响低频范围。
  • 随访显示ABR持续异常或缺失,DPOAE逐渐消失,CM保持稳定,言语识别得分持续较差。

关键数值与推荐

  • OTOF和ATP1A3突变携带者发病早且听阈差,AIFM1突变携带者发病晚且听阈较好(多重比较)。
  • 助听器干预以双侧为主,人工耳蜗植入以单侧为主。
  • 人工耳蜗植入者较助听器使用者诊断年龄和发病年龄更低,助听后听阈更优。

临床怎么用

  • 临床应重视CM在听神经病评估外毛细胞功能中的作用。
  • 对听神经病患者需长期随访听力进展和言语识别能力。
  • 根据突变基因类型(如OTOF、ATP1A3、AIFM1)可辅助预测发病年龄和听阈特点。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Over the past 30 years, significant advancements have been made in auditory neuropathy (AN) research. The study aimed to explore auditory function and the natural history of AN from neonates to adulthood based on a large Chinese AN patient population. DESIGN: This retrospective case series included 645 patients diagnosed with AN at our institution, the Chinese PLA General Hospital, over a 27-year period from January 1997 to December 2023. All patients had an absent or abnormal auditory brainstem response (ABR), normal or slightly altered otoacoustic emissions and/or cochlear microphonics (CM), and binaural onset. RESULTS: The study enrolled patients who were from 29 provinces and 11 different ethnic groups in China. The diagnostic rate of AN has ranged from 1 case per year to 44 diagnoses per year. The study assessed the typical auditory characteristics of individuals at various ages at diagnosis. Statistically significant differences were found in the elicitation rates of ABR, distortion product otoacoustic emissions, acoustic stapedius reflex threshold, pure-tone average, 40 Hz auditory event-related potential, and progress of speech discrimination scores in AN patients from neonates to adulthood; however, the elicitation of CM ranged from 96.36 to 100% from neonates to adulthood. A relatively large proportion of AN patients had hearing loss predominantly affecting the lower frequency range. Follow-up results showed that patients with AN had stable abnormal or absent ABR, distortion product otoacoustic emissions gradually disappeared, but CM remained stable, and poor speech discrimination scores persisted. Distinct clinical profiles were observed in patients with AN carrying pathogenic or likely pathogenic mutations, including OTOF, AIFM1, ATP1A3, WFS1 , and OPA1 . OTOF and ATP1A3 mutation carriers had early onset and poor hearing thresholds, while AIFM1 had later onset and better hearing thresholds by multiple comparisons. Interventions included hearing aids with mainly bilateral interventions, and cochlear implants with predominantly unilateral intervention. Cochlear implant recipients showed lower diagnostic and onset ages and superior aided hearing thresholds compared with hearing aid users. CONCLUSIONS: Advances in disease awareness, hearing screening, and diagnostic methods have enabled early detection and diagnosis of AN. Follow-up results highlighted the importance of CM in evaluating the function of outer hair cells. AN patients experienced a higher frequency of hearing loss progression while maintaining poor, unchangeable speech recognition ability. This study elucidates the multifaceted nature of AN, thereby establishing a more comprehensive understanding of the diagnosis and management of AN. Moreover, it serves as a pivotal reference for guiding counseling and evaluating the prognoses of clinical AN patients.

来源:Ear Hear,查看原文。版权归原作者所有。

引用

  1. Zhou X, Wu X, Li D, et al. Auditory Function and Natural History of 645 Auditory Neuropathy Patients Over a 27-Year Span in China. Ear Hear. 2025. PMID: 41453019. doi:10.1097/AUD.0000000000001746

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。